Cointime

Biospect

company

About

Biospect Inc., a South San Francisco-based life sciences company launched last year to detect protein biomarker patterns.

  • 1 - 10

Highlights

Total Funding Amount
$27M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series B
Last Funding Money Raised
$27M
Industries
Biotechnology,Health Care,Life Science
Founded date
Jan 1, 2002
Number Of Employee
1 - 10
Operating Status
Active

Biospect, Inc. is developing minimally invasive technology for identifying and assaying protein biomarker patterns that reflect and differentiate biological states. The integrated Biospect system consists of proprietary separations, detection and informatics technologies, and is targeted for use in diagnosing and managing disease or drug development. Biospect is backed by Advent Venture Partners, Prospect Venture Partners, Venrock Associates and Versant Ventures and was incubated by Prospect Venture Partners.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$27M
Biospect has raised a total of $27M in funding over 2 rounds. Their latest funding was raised on Oct 21, 2003 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 21, 2003 Series B $27M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Biospect is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures — Series B
Cointime
เนื้อหา
บริษัท